Literature DB >> 15548970

Urolithiasis after kidney transplantation in pediatric recipients: a single center report.

Sookkasem Khositseth1, Kristen J Gillingham, Marie E Cook, Blanche M Chavers.   

Abstract

BACKGROUND: Urolithiasis occurs in approximately 6% of adult kidney transplant (KTx) recipients. Limited data are available on urolithiasis after pediatric KTx. We report the incidence, management of, and risk factors for stone development in children after KTx.
METHODS: We reviewed the medical records of 399 children who received KTx at our center between September 1986 and January 2003. Transplant outcomes were compared in stone formers and controls.
RESULTS: Twenty (5%) patients, age 9+/-5 (X +/- SD) years, developed stones over the follow-up period (74+/-53 months). Time to stone presentation was 19+/-22 months post-KTx. Presenting features were urinary tract infection (UTI), 8; gross hematuria, 5; microscopic hematuria, 2; dysuria without infection, 6; difficulty voiding, 3; and silent stones, 2. Stones were removed by cystoscopy in 11 (55%) patients. Stone composition was determined in 11 patients: calcium phosphate (55%), calcium oxalate (18%), mixed calcium phosphate and oxalate (9%), and struvite (18%). Factors predisposing to stones in study patients included suture retention (n = 4), elevated urinary calcium excretion (n = 2), recurrent UTI (n = 2), and urinary stasis (n = 2). The incidence of UTI was higher (P = 0.003) and of acute rejection was lower (P = 0.02) in stone patients compared with controls. Patient and graft survival rates and the incidence of chronic rejection did not significantly differ between study patients and controls (P = NS).
CONCLUSIONS: Urolithiasis is not uncommon in pediatric KTx patients. Factors associated with post-KTx urolithiasis include retention of suture material, recurrent UTI, hypercalciuria, and urinary stasis. Treatment is associated with excellent outcome and low recurrence rate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15548970     DOI: 10.1097/01.tp.0000139543.56886.de

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation.

Authors:  Ludwig Stapenhorst; Robert Sassen; Bodo Beck; Norbert Laube; Albrecht Hesse; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

2.  Incidence of kidney stones in kidney transplant recipients: A systematic review and meta-analysis.

Authors:  Wisit Cheungpasitporn; Charat Thongprayoon; Michael A Mao; Wonngarm Kittanamongkolchai; Insara J Jaffer Sathick; Tsering Dhondup; Stephen B Erickson
Journal:  World J Transplant       Date:  2016-12-24

3.  Safety of potassium-bearing citrate in patients with renal transplantation: A case report.

Authors:  Lin Wang; Yinglin Cui; Jianwei Zhang; Qinsheng Zhang
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

4.  Treatment of recurrent renal transplant lithiasis: analysis of our experience and review of the relevant literature.

Authors:  Xiaohang Li; Baifeng Li; Yiman Meng; Lei Yang; Gang Wu; Hongwei Jing; Jianbin Bi; Jialin Zhang
Journal:  BMC Nephrol       Date:  2020-06-23       Impact factor: 2.388

5.  Bardet-Biedl syndrome, renal transplant and percutaneous nephrolithotomy: a case report and review of the literature.

Authors:  Seshikanth Middela; Konstantinos Polizois; Alison J Bradley; Poduri N Rao
Journal:  Cases J       Date:  2009-07-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.